Remarkably, Tie2 dysregulation has been implicated in both atherosclerosis and thrombosis, as well as in functional processes such as migration and angiogenesis, demonstrating that Tie2 has a prominent role in cardiovascular events that are dysregulated in patients with SLE (19, 20). Here, TEK is linked to atherosclerosis.